August 24, 2020 Update: The U.S. Food and Drug Administration issued an Emergency Use Authorization on August 23, 2020 for emergency use of convalescent plasma for the treatment of hospitalized patients with severe COVID-19. A clinical trial testing the investigational use of convalescent plasma for COVID-19 is closed to participant enrollment at Sutter.
Above: Sutter Health leaders, caregivers and community partners celebrate the opening of Second Harvest of the Greater Valley's expanded food distribution facility in Manteca, a project supported by a $2.5 million investment from Sutter Health. Pairings can bring...
(shown above, Pathfinder 2 investigator Dr. Charles McDonnell outside Sutter Medical Center in Sacramento) By Karin Fleming & Nicole Young, Vitals Contributors An FDA advisory panel endorsed GRAIL’s Galleri® multi-cancer early detection blood test, after...
[bc_video video_id="6405640280112" account_id="817826402001" player_id="IimrtJUbLY" embed="in-page" padding_top="360px" autoplay="" playsinline="" picture_in_picture="" language_detection="" application_id="" mute="" width="640px" height="360px" aspect_ratio="16:9"...
By Dr. Leila Haghighat, Vitals contributor Prostate cancer is the second most commonly diagnosed cancer in American men. Yet for decades, men diagnosed with localized prostate cancer have faced a difficult choice. They could monitor the cancer closely or treat the...